The proportion of people being diagnosed with early-onset Parkinson’s is on the rise. Dr Victor Dieriks lays out four ...

Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...

As per the filing, Biogen has a 10.2% stake in Sage Therapeutics. Biogen has been navigating a slow pick-up in sales for its ...

Normandie University researchers have identified critical links between the brain's inhibitory memory control mechanisms and ...

Some children wit neurological disorders - mostly for Nigeria rural areas - dey labelled as witches. In some cases, dem dey ...

(Alliance News) - RTW Biotech Opportunities Ltd said on Friday said it is participating in a EUR65 million Series A financing round for Alesta Therapeutics BV, a Leiden, Netherlands-based ...

Matthew Hearing, an associate professor of biomedical sciences at Marquette University’s college of health sciences, has ...

Precision BioSciences (DTIL) stock saw a 31% premarket surge after positive results from its gene therapy trial for treating ...

After their son’s diagnosis, the Hall family is raising millions for ALD research—giving kids a fighting chance at life.

NervGen is engaged in groundbreaking research in spinal cord injury treatment. Read here for an update on the research's ...

Arrivo BioVentures today announced positive data from its SP-624-103 study evaluating the impact of SP-624's novel epigenetic mechanism of action on neurological pathways. The findings provide ...

Most mutations which cause disease by swapping one amino acid out for another do so by making the protein less stable, ...